Publications by authors named "M G Huisse"
Article Synopsis
- Myeloproliferative neoplasms (MPN) increase the risk of blood clots, and pegylated-interferon alpha (IFN) and hydroxyurea (HU) are common treatments for these conditions.
- The study examined how IFN and HU affect blood clotting markers in 85 MPN patients, finding that IFN treated patients had significantly elevated hemostatic markers compared to those not on treatment.
- The research suggests that IFN therapy has major and reversible effects on blood coagulation in MPN patients, but further studies are needed to explore its potential link to increased clotting risks.
Correction to: Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.
Intensive Care Med
January 2018
The members of the Palurea Study Group were provided in such a way that they could not be indexed as collaborators on PubMed. The publisher apologizes for this error and is pleased to list the members of the group here.
View Article and Find Full Text PDFAims: To determine antiplatelet efficacy after desensitization in patients with a history of aspirin hypersensitivity.
Methods And Results: We conducted a case-control study to evaluate the efficacy of aspirin 1 day (D1) and 6-8 weeks (W6-8) after desensitization. We also assessed ex vivo basophil reactivity to aspirin after desensitization.
Purpose: Prospective data on potential factors associated with severity of imported Plasmodium falciparum malaria are lacking. We evaluated whether several host- and parasite-related biomarkers may improve early severity evaluation.
Methods: Prospective multicenter observational study comparing uncomplicated and severe imported falciparum malaria in adults conducted in France in 52 units, from 2007 to 2010.
Impact of diabetes mellitus and metabolic syndrome on acute and chronic on-clopidogrel platelet reactivity in patients with stable coronary artery disease undergoing drug-eluting stent placement.
Am Heart J
December 2014
Background: Previous studies, which compared the prevalence of high on-clopidogrel platelet reactivity (HCPR) in type 2 diabetes mellitus (T2DM) versus non-T2DM and obese versus nonobese patients provided conflicting results.
Methods: We compared the prevalence of HCPR in patients with T2DM, metabolic syndrome (MS), or neither T2DM nor MS undergoing drug-eluting stent implantation for stable coronary artery disease. Platelet functions were measured after a 600-mg clopidogrel loading dose and after 4 months on clopidogrel 75 mg/d.